Xeriant Inc (XERI): 10Q isn't worth any comments! What w...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Tuesday, 05/17/2022 8:40:02 AM

Tuesday, May 17, 2022 8:40:02 AM

10Q isn't worth any comments! What we could use is some Movychem Retacell update. Is Retacell poised to deliver revenue or not?

Keep Last Read

Next 10 Prev Next

Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 03/08/2024 06:00:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 05:43:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:35:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:01 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/16/2023 11:27:32 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:57:53 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 10:01:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 08:21:47 PM

InvestorsHub NewsWire

Only $200 per official company press release!